Metabolic fates of 2′-deoxy-5-[18F]fluorouridine in tumor-bearing mice and human plasma
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Vol. 18 (5) , 539-545
- https://doi.org/10.1016/0883-2897(91)90115-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivoBritish Journal of Cancer, 1989
- In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolismInvestigational New Drugs, 1989
- Automated synthesis of 5-[18F]fluoro-2′-deoxyuridineInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1987
- β-AMINO ACIDS: MAMMALIAN METABOLISM AND UTILITY AS α-AMINO ACID ANALOGUESAnnual Review of Biochemistry, 1986
- Orbital Tumor Diagnosis by Positron Emission Tomography Using 18F-FluorodeoxyuridineOphthalmic Research, 1986
- Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and miceEuropean Journal of Nuclear Medicine and Molecular Imaging, 1985
- 5-Flourouracil metabolism monitored in vivo by 19F NMRBritish Journal of Cancer, 1984
- Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1983
- Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injectionAmerican Journal of Physiology-Legacy Content, 1971
- Studies on fluorinated pyrimidines: VII—the degradative pathwayBiochemical Pharmacology, 1959